OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A humanized mouse model of chronic COVID-19
Esen Sefik, Benjamin Israelow, Haris Mirza, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 6, pp. 906-920
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Inflammasome activation in infected macrophages drives COVID-19 pathology
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 585-593
Open Access | Times Cited: 422

Comorbidities, multimorbidity and COVID-19
Clark D Russell, Nazir Lone, J. Kenneth Baillie
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 334-343
Open Access | Times Cited: 233

Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 94

SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 92

SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin C. Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 88

Animal models for COVID-19: advances, gaps and perspectives
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 79

Long-Term Outcomes of Pediatric Infections: From Traditional Infectious Diseases to Long Covid
Danilo Buonsenso, Leonardo Di Gennaro, Cristina De Rose, et al.
Future Microbiology (2022) Vol. 17, Iss. 7, pp. 551-571
Open Access | Times Cited: 76

Persistent SARS-CoV-2 infection: significance and implications
Heather Machkovech, Anne M. Hahn, Jacqueline Garonzik‐Wang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. e453-e462
Open Access | Times Cited: 52

SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 14

Immune determinants of chronic sequelae after respiratory viral infection
Harish Narasimhan, Yue Wu, Nick P. Goplen, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 38

Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond
Anthony R. Sciaudone, Heather A. Corkrey, Fiachra Humphries, et al.
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1272-1289
Open Access | Times Cited: 38

Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
Obdulio García-Nicolás, Aurélie Godel, Gert Zimmer, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 835-849
Open Access | Times Cited: 22

Comparative single-cell analysis reveals IFN-γ as a driver of respiratory sequelae after acute COVID-19
Chaofan Li, Wei Qian, Xiaoqin Wei, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 756
Closed Access | Times Cited: 12

Monocytes and macrophages: Origin, homing, differentiation, and functionality during inflammation
Shiba Prasad Dash, Saloni Gupta, Pranita P. Sarangi
Heliyon (2024) Vol. 10, Iss. 8, pp. e29686-e29686
Open Access | Times Cited: 10

A defective viral genome strategy elicits broad protective immunity against respiratory viruses
Yinghong Xiao, Peter V. Lidsky, Yuta Shirogane, et al.
Cell (2021) Vol. 184, Iss. 25, pp. 6037-6051.e14
Open Access | Times Cited: 54

Current Status of Putative Animal Sources of SARS-CoV-2 Infection in Humans: Wildlife, Domestic Animals and Pets
Max Maurin, Florence Fenollar, Oleg Mediannikov, et al.
Microorganisms (2021) Vol. 9, Iss. 4, pp. 868-868
Open Access | Times Cited: 45

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
Cédric Bosteels, Karel Van Damme, Elisabeth De Leeuw, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 12, pp. 100833-100833
Open Access | Times Cited: 31

Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development
Julie Bigay, Roger Le Grand, Frédéric Martinon, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29

Epiregulin is a dendritic cell–derived EGFR ligand that maintains skin and lung fibrosis
Ian D. Odell, Holly R. Steach, Stephen B. Gauld, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 27

Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice
Anna Chen, Ines Neuwirth, Dietmar Herndler‐Brandstetter
Cancers (2023) Vol. 15, Iss. 11, pp. 2989-2989
Open Access | Times Cited: 17

Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2 -infected mice and reduces endotheliopathy
María Ángeles Rodríguez-Hernández, Mercedes Baena-Bustos, David Carneros, et al.
EBioMedicine (2024) Vol. 103, pp. 105132-105132
Open Access | Times Cited: 6

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
Shen Wang, Wujian Li, Zhenshan Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6

Beneficial and Detrimental Effects of Cytokines during Influenza and COVID-19
De Chang, Charles S. Dela Cruz, Lokesh Sharma
Viruses (2024) Vol. 16, Iss. 2, pp. 308-308
Open Access | Times Cited: 5

A murine model of post-acute neurological sequelae following SARS-CoV-2 variant infection
Ankita Singh, Awadalkareem Adam, Aditi Aditi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Animal models of Long Covid: A hit-and-run disease
Alexandra Schaefer, Sarah R. Leist, John M. Powers, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top